Early intensive therapy versus escalation strategy in French Caribbean multiple sclerosis cohort
European Journal of Neurology · 2025-02 · 32 (2)
DOI: 10.1111/ene.70030 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Neurology, online erschienen am 30.01.2025. Verfasst von Thomas David und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital of Guadeloupe, Pointe-à-Pitre/Abymes, Guadeloupe, France. Hauptthemen laut MEDLINE: Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Data on Escalation Therapy versus Early Intensive Therapy (EIT) Strategy in multiple sclerosis (MS) are lacking, particularly in Afro‐Caribbean cases, known for their severity.
Objectives
To assess efficacy and safety of these strategies in a predominantly Afro‐Caribbean relapsing–remitting MS population.
Methods
A multicenter retrospective study of 195 MS patients, including 66 on EIT, with ≥2 years follow‐up. Primary outcome: Kaplan–Meier curves and log‐rank test were used to assess irreversible progression to EDSS scores of 3, 6, and 8. Secondary outcomes: change in EDSS score, risk factors for EDSS progression, and severe adverse effects.
Results
EIT showed slower EDSS 3 progression than Escalation (median survival 13.5 vs. 9.8 years, p = 0.024). After a median follow‐up of 8 years, 89.5% on EIT remained free from EDSS 3 versus 63.8% on Escalation. Univariate analysis linked Escalation (hazard ratio (HR; 95% CI): 2.42 [1.09–5.34]), age at first relapse (HR: 1.04 [1.01–1.06]), incomplete symptom regression (HR: 1.69 [1.02–2.77]), and EDSS 3 progression. EDSS stabilized or decreased with EIT but worsened with Escalation ( p < 0.001). Safety profiles were similar.
Conclusions
EIT extends median time to irreversible EDSS 3 in Afro‐Caribbean individuals compared to Escalation, supporting its preference as initial treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Hospital of Guadeloupe, Pointe-à-Pitre/Abymes, Guadeloupe, France.
- Faculty of Medicine, University of the Antilles, Pointe-à-Pitre, France.
- Department of Neurology, Pierre Zobda-Quitman University Hospital, Fort de France, Martinique, France.
- Antilles Guyane Clinical Investigation Center, Inserm CIC 1424, University Hospital of Guadeloupe, Pointe-à-Pitre/Abymes, Guadeloupe, France.
- Faculty of Medicine, Sorbonne University, Paris, France.
- National Institute of Health and Medical Research, U 1127, CNRS, Joint Research Unit (UMR) 7225, Brain Institute, ICM, Paris, France.
ORCID-Profile: Annie Lannuzel, Hugo Chaumont
Zitieren
APA
David, T., Lobjois, Q., Tressières, B., Signaté, A., Lannuzel, A., Cabre, P., & Chaumont, H. (2025). Early intensive therapy versus escalation strategy in French Caribbean multiple sclerosis cohort. European Journal of Neurology, 32(2). https://doi.org/10.1111/ene.70030
Vancouver
David T, Lobjois Q, Tressières B, Signaté A, Lannuzel A, Cabre P, et al. Early intensive therapy versus escalation strategy in French Caribbean multiple sclerosis cohort. European Journal of Neurology. 2025;32(2). doi:10.1111/ene.70030
BibTeX
@article{David2025,
author = {David, Thomas and Lobjois, Quentin and Tressières, Benoit and Signaté, Aissatou and Lannuzel, Annie and Cabre, Philippe and Chaumont, Hugo},
title = {Early intensive therapy versus escalation strategy in French Caribbean multiple sclerosis cohort},
journal = {European Journal of Neurology},
year = {2025},
volume = {32},
number = {2},
doi = {10.1111/ene.70030}
}
EUVIMED